Assignee
SYNERGENE THERAPEUTICS INC
US·2 granted patents·3 pending applications·9 citations·filing 2000–2024
Top patents by PatentIndex Score
5 records- 0176US7479276B1Antibody fragment-targeted immunoliposomes for systemic gene deliverySYNERGENE THERAPEUTICS INC·Filed 2000·Granted Jan 20, 2009·9 cites·14 claims
- 0264US2008213223A1Systemic viral/ligand gene delivery system and gene therapySYNERGENE THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 0363US2024366507A1Methods of Treating Neurologic DisordersSYNERGENE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0459US2009191261A1Antibody fragment-targeted immunoliposomes for systemic gene deliverySYNERGENE THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 0549US12274784B2Methods for reducing side effects of immunotherapySYNERGENE THERAPEUTICS INC·Filed 2019·Granted Apr 15, 2025·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when SYNERGENE THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →